No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
An algorithm for shifting MLC shapes to adjust for daily prostate movement during concurrent treatment with pelvic lymph nodesa)
1.M. Roach III, M. DeSilvio, C. Lawton, V. Uhl, M. Machtay, M. J. Seider, M. Rotman, C. Jones, S. O. Asbell, R. K. Valicenti, S. Han, C. R. Thomas, Jr., and W. S. Shipley, “Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413,” J. Clin. Oncol. 21, 1904–1911 (2003).
2.S. O. Asbell, J. M. Krall, M. V. Pilepich, H. Baerwald, W. T. Sause, G. E. Hanks, and C. A. Perez, “Elective pelvic irradiation in stage A2, B carcinoma of the prostate: Analysis of RTOG 77-06,” Int. J. Radiat. Oncol. Biol. Phys. 15, 1307–1316 (1988).
3.D. G. McGowan, “The value of extended field radiation therapy in carcinoma of the prostate,” Int. J. Radiat. Oncol. Biol. Phys. 7, 1333–1339 (1981).
4.S. Ploysongsang, B. S. Aron, W. M. Shehata, F. K. Jazy, R. M. Scott, P. Y. Ho, and T. M. Morand, “Comparison of whole pelvis versus small-field radiation therapy for carcinoma of prostate,” Urology 27, 10–16 (1986).
5.S. A. Seaward, V. Weinberg, P. Lewis, B. Leigh, T. L. Phillips, and M. Roach III, “Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer,” Int. J. Radiat. Oncol. Biol. Phys. 42, 1055–1062 (1998).
6.C. E. Vargas, R. Galalae, J. Demanes, A. Harsolia, E. Meldolesi, N. Nurnberg, L. Schour, and A. Martinez, “Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation,” Int. J. Radiat. Oncol. Biol. Phys. 17, 17 (2005).
7.S. S. Ploysongsang, B. S. Aron, and W. M. Shehata, “Radiation therapy in prostate cancer: Whole pelvis with prostate boost or small field to prostate?” Urology 40, 18–26 (1992).
8.N. Rangala, J. D. Cox, R. W. Byhardt, J. F. Wilson, M. Greenberg, and A. Lopes da Conceicao, “Local control and survival after external irradiation for adenocarcinoma of the prostate,” Int. J. Radiat. Oncol. Biol. Phys. 8, 1909–1914 (1982).
9.H. A. Shih, M. Harisinghani, A. L. Zietman, J. A. Wolfgang, M. Saksena, and R. Weissleder, “Mapping of nodal disease in locally advanced prostate cancer: Rethinking the clinical target volume for pelvic nodal irradiation based on vascular rather than bony anatomy,” Int. J. Radiat. Oncol. Biol. Phys. 63, 1262–1269 (2005).
10.A. Wang-Chesebro, P. Xia, J. Coleman, C. Akazawa, and M. Roach III, “Intensity-modulated radiotherapy improves lymph node coverage and dose to critical structures compared with three-dimensional conformal radiation therapy in clinically localized prostate cancer,” Int. J. Radiat. Oncol. Biol. Phys. 66, 654–662 (2006).
11.C. J. Beard, P. Kijewski, M. Bussiere, R. Gelman, D. Gladstone, K. Shaffer, M. Plunkett, P. Castello, and C. N. Coleman, “Analysis of prostate and seminal vesicle motion: Implications for treatment planning,” Int. J. Radiat. Oncol. Biol. Phys. 34, 451–458 (1996).
13.J. C. Roeske, J. D. Forman, C. F. Mesina, T. He, C. A. Pelizzari, E. Fontenla, S. Vijayakumar, and G. T. Chen, “Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy,” Int. J. Radiat. Oncol. Biol. Phys. 33, 1321–1329 (1995).
14.J. C. Stroom, P. C. Koper, G. A. Korevaar, M. van Os, M. Janssen, H. C. de Boer, P. C. Levendag, and B. J. Heijmen, “Internal organ motion in prostate cancer patients treated in prone and supine treatment position,” Radiother. Oncol. 51, 237–248 (1999).
15.R. K. Ten Haken, J. D. Forman, D. K. Heimburger, A. Gerhardsson, D. L. McShan, C. Perez-Tamayo, S. L. Schoeppel, and A. S. Lichter, “Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder,” Int. J. Radiat. Oncol. Biol. Phys. 20, 1317–1324 (1991).
16.M. van Herk, A. Bruce, A. P. Kroes, T. Shouman, A. Touw, and J. V. Lebesque, “Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration,” Int. J. Radiat. Oncol. Biol. Phys. 33, 1311–1320 (1995).
17.M. J. Zelefsky, D. Crean, G. S. Mageras, O. Lyass, L. Happersett, C. C. Ling, S. A. Leibel, Z. Fuks, S. Bull, H. M. Kooy, M. van Herk, and G. J. Kutcher, “Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy,” Radiother. Oncol. 50, 225–234 (1999).
18.A. Hsu, T. Pawlicki, G. Luxton, W. Hara, and C. R. King, “A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes,” Int. J. Radiat. Oncol. Biol. Phys. 68, 898–902 (2007).
19.J. B. Ashman, M. J. Zelefsky, M. S. Hunt, S. A. Leibel, and Z. Fuks, “Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy,” Int. J. Radiat. Oncol. Biol. Phys. 63, 765–771 (2005).
20.M. L. Cavey, J. E. Bayouth, M. Colman, E. J. Endres, and G. Sanguineti, “IMRT to escalate the dose to the prostate while treating the pelvic nodes,” Strahlenther. Onkol. 181, 431–441 (2005).
21.G. Sanguineti, M. L. Cavey, E. J. Endres, G. G. Brandon, and J. E. Bayouth, “Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer?” Int. J. Radiat. Oncol. Biol. Phys. 64, 151–160 (2006).
22.R. Mohan, X. Zhang, H. Wang, Y. Kang, X. Wang, H. Liu, K. K. Ang, D. Kuban, and L. Dong, “Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes,” Int. J. Radiat. Oncol. Biol. Phys. 61, 1258–1266 (2005).
23.L. E. Court, L. Dong, A. K. Lee, R. Cheung, M. D. Bonnen, J. O'Daniel, H. Wang, R. Mohan, and D. Kuban, “An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer,” Int. J. Radiat. Oncol. Biol. Phys. 62, 154–163 (2005).
24.Y. Feng, C. Castro-Pareja, R. Shekhar, and C. Yu, “Direct aperture deformation: An interfraction image guidance strategy,” Med. Phys. 33, 4490–4498 (2006).
25.K. E. Deurloo, R. J. Steenbakkers, L. J. Zijp, J. A. de Bois, P. J. Nowak, C. R. Rasch, and M. van Herk, “Quantification of shape variation of prostate and seminal vesicles during external beam radiotherapy,” Int. J. Radiat. Oncol. Biol. Phys. 61, 228–238 (2005).
Article metrics loading...
Full text loading...
Most read this month